Abstract
The effect of methylprednisolone on fresh cells from patients with chronic lymphocytic leukaemia (CLL) has been studied using the differential staining cytotoxicity (DiSC) assay resulting in LC90s of < or = 0.2 to 2,000 micrograms/ml. Cells from previously treated patients were, on average, significantly more sensitive to methylprednisolone than those from untreated patients (mean LC90 = 5.7 micrograms/ml, n = 61 vs 31.0 micrograms/ml, n = 17, respectively; p < 0.05). Twelve patients with advanced disease were given high-dose methylprednisolone (1 g/m2/day i.v. x 5 days). In 7 cases, > or = 3 courses were given; 3 patients did not respond (2 achieved palliation) and 4 (57%) achieved a good partial response. These latter 4 patients were all clinically resistant to chlorambucil and anthracyclines and 2 were resistant to fludarabine. In 5 cases, 1 or 2 courses were given but no patients responded. The 8 nonresponders survived a median of 3.5 months whilst the responders have survived a median of 28.5+ months (3 of 4 still alive). This work suggests a rationale for why CLL patients resistant to standard chemotherapy may benefit from high-dose methylprednisolone therapy. Due to cost and toxicity associated with therapy, the decision...Continue Reading
Citations
Aug 31, 2002·Hematological Oncology·Gerassimos A PangalisMaria K Angelopoulou
Feb 1, 1996·Leukemia Research·A G Bosanquet, P B Bell
Dec 23, 2003·Leukemia Research·Vincent GentyJean Dufer
Aug 12, 1999·British Journal of Haematology·A G BosanquetS M Richards
Sep 18, 2012·Journal of Hematology & Oncology·Kang Lu, Xin Wang
May 23, 2001·Drugs·T J Hamblin
Oct 25, 2008·Leukemia & Lymphoma·Andrew R Pettitt
May 24, 2011·Leukemia & Lymphoma·Regina PileckyteLaimonas Griskevicius
Jun 1, 1999·Leukemia & Lymphoma·P D ThorntonD Catovsky
Oct 31, 2006·Leukemia & Lymphoma·Michael NerenbergAlan Saven
Dec 11, 2007·Leukemia & Lymphoma·Deborah A BowenTait D Shanafelt
May 24, 2012·Expert Opinion on Investigational Drugs·Lukáš Smolej
Jul 16, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Wei XuJian-Yong Li
Nov 6, 2002·Journal of Experimental Therapeutics & Oncology·Andrew G BosanquetPhilip B Bell
Jun 1, 2002·Leukemia·T Robak, M Kasznicki
Jun 1, 2002·Leukemia·A G BosanquetP T Daniel
Jun 17, 2005·Expert Opinion on Pharmacotherapy·Kim M GoorMichel van Agthoven
Dec 7, 2011·Cancer Control : Journal of the Moffitt Cancer Center·Marays Veliz, Javier Pinilla-Ibarz
Sep 12, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maria Joao BaptistaFrancesc Bosch